Form 8-K - Current report:
SEC Accession No. 0001437749-21-014906
Filing Date
2021-06-16
Accepted
2021-06-16 08:00:39
Documents
25
Period of Report
2021-06-16
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K snbp20210615_8k.htm 8-K 28214
2 EXHIBIT 99.1 ex_257652.htm EX-99.1 38909
3 p01.jpg GRAPHIC 177729
4 p02.jpg GRAPHIC 330592
5 p03.jpg GRAPHIC 165253
6 p04.jpg GRAPHIC 151150
7 p05.jpg GRAPHIC 158715
8 p06.jpg GRAPHIC 214410
9 p07.jpg GRAPHIC 246141
10 p08.jpg GRAPHIC 237484
11 p09.jpg GRAPHIC 347400
12 p10.jpg GRAPHIC 225195
13 p11.jpg GRAPHIC 212307
14 p12.jpg GRAPHIC 161758
15 p13.jpg GRAPHIC 203885
16 p14.jpg GRAPHIC 160757
17 p15.jpg GRAPHIC 307793
18 p16.jpg GRAPHIC 129651
19 p17.jpg GRAPHIC 130194
20 p18.jpg GRAPHIC 177842
21 p19.jpg GRAPHIC 168949
22 p20.jpg GRAPHIC 164368
23 p21.jpg GRAPHIC 140962
24 p22.jpg GRAPHIC 95257
25 p23.jpg GRAPHIC 173638
  Complete submission text file 0001437749-21-014906.txt   6239293
Mailing Address 712 VISTA BLVD #305 WACONIA MN 55387
Business Address 712 VISTA BLVD #305 WACONIA MN 55387 9524791196
Panbela Therapeutics, Inc. (Filer) CIK: 0001029125 (see all company filings)

EIN.: 870543922 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39468 | Film No.: 211020508
SIC: 2834 Pharmaceutical Preparations